Provided by Tiger Fintech (Singapore) Pte. Ltd.

Guardant Health Inc.

94.97
+22.7031.41%
Volume:4.53M
Turnover:420.33M
Market Cap:11.97B
PE:-28.39
High:95.88
Open:90.00
Low:88.22
Close:72.27
52wk High:95.88
52wk Low:21.28
Shares:126.04M
Float Shares:119.55M
Volume Ratio:6.27
T/O Rate:3.79%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-3.3453
EPS(LYR):-3.5551
ROE:-4584.47%
ROA:-19.57%
PB:-39.19
PE(LYR):-26.71

Loading ...

Oct 29, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Oct 29, 2025

Major Issues Report

Form 8-K - Current report
Oct 17, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Oct 17, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Sep 24, 2025

Major Issues Report

Form 8-K - Current report
Sep 17, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Sep 17, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Sep 15, 2025

Major Issues Report

Form 8-K - Current report
Sep 12, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Sep 09, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Sep 03, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 21, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 19, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 19, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jul 30, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Jul 30, 2025

Major Issues Report

Form 8-K - Current report
Jul 17, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jul 17, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 20, 2025

Major Issues Report

Form 8-K - Current report
Jun 18, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities